It's Time To End The Band-Aid Fixes For The U.S. Power Grid: The Urgent Case For Grid Transformation
The U.S. power grid is indispensable infrastructure for our economy, but warning signs are flashing about its health that should concern every business leader in our country. Skyrocketing growth in ...
Cartesian Growth Corp. III Class A ( (CGCT)) just unveiled an announcement. On December 17, 2025, Cartesian Growth Corporation III and Factorial Inc. signed a definitive business combination agreement ...
Factorial’s high-power, lightweight, solid-state batteries have demonstrated real-world performance, including over 1,200 km (745 miles) of driving range in vehicle testing and are being advanced ...
An early grid battery was installed in the Atacama Desert in Chile 15 years ago. Now, as prices have tumbled, they are increasingly being used around the world. Andes Solar IV, one of the largest ...
Artificial Intelligence (AI) is now a major force in the U.S. economy. The rapid expansion of data centers in the United States has emphasized the challenges facing the U.S. electricity sector, which ...
Massive data centers are pushing energy demand higher. Some people claim that AI will be a net benefit for the grid. The rising popularity of AI is driving an increase in electricity demand so ...
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases, eliminating the need for preconditioning chemotherapy. Lead candidate Descartes-08 showed promising ...
Instagram announced on Thursday that it will finally allow users to rearrange their grid and is testing a way for users to quietly post to their profile without having the content appear in users’ ...
Cartesian Therapeutics, Inc. has announced the enrollment of the first participant in its Phase 3 AURORA trial for Descartes-08, its lead cell therapy candidate aimed at treating myasthenia gravis (MG ...
FREDERICK, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...
NEW YORK--(BUSINESS WIRE)--Cartesian Growth Corporation III (the “Company”) announced today the pricing of its initial public offering of 24,000,000 units, upsized from 20,000,000 units, at a price of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results